EchoSolv AS vs Eko Low Ejection Fraction Tool (ELEFT)
AI Verdict
Choose EchoSolv AS if…
Choose EchoSolv AS if your cardiology department needs to efficiently and accurately identify patients at high risk for severe aortic stenosis from existing echocardiogram measurements. This tool is ideal for streamlining the review process, providing consistent probability assessments, and offering second-reader support to prioritize studies for closer review within seconds.
View EchoSolv AS →Choose Eko Low Ejection Fraction Tool (ELEFT) if…
Choose Eko Low Ejection Fraction Tool (ELEFT) if you are a clinician in a primary care or general practice setting seeking a non-invasive, point-of-care screening tool for early detection of low ejection fraction, a key indicator of heart failure. This AI-powered solution integrates seamlessly with Eko digital stethoscopes during routine physical exams, providing rapid results to aid in proactive heart care.
View Eko Low Ejection Fraction Tool (ELEFT) →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | EchoSolv AS | Eko Low Ejection Fraction Tool (ELEFT) |
|---|---|---|
| Deployment | Cloud-based | Unknown |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
EchoSolv ASEchoSolv AS (Tool A) is designed to integrate seamlessly into existing PACS workflows without requiring EMR integration, offering ultra-fast risk detection in under 3 seconds. Eko Low Ejection Fraction Tool (ELEFT) (Tool B) requires integration with proprietary Eko digital stethoscopes and provides results in approximately 15 seconds, which could introduce additional hardware and workflow considerations.
Clinical Value
Eko Low Ejection Fraction Tool (ELEFT)Both tools offer significant clinical value and are FDA-cleared. EchoSolv AS (Tool A) provides precise decision support for severe aortic stenosis from echocardiogram data. ELEFT (Tool B) offers early, non-invasive detection of low ejection fraction, a key indicator of heart failure, during routine physical exams, potentially enabling broader screening and earlier intervention in primary care settings.
Pricing & Value
Eko Low Ejection Fraction Tool (ELEFT)ELEFT (Tool B), as part of Eko's SENSORAu2122 platform, has an established CMS reimbursement rate of $128.90 per use, providing a clear financial pathway for health systems. EchoSolv AS (Tool A) operates on a subscription-based model and has identified a miscellaneous code for reimbursement between $100-$150 per use, but is still working towards a dedicated CPT code.
Enterprise Readiness
Eko Low Ejection Fraction Tool (ELEFT)Both tools are FDA-cleared, HIPAA compliant, and offer BAAs. While EchoSolv AS (Tool A) emphasizes integration with existing PACS, ELEFT (Tool B) is explicitly positioned as an 'enterprise solution' and has secured a CMS reimbursement rate for its SENSORA platform, which significantly de-risks adoption and provides a clear financial pathway for health systems.
Innovation
Eko Low Ejection Fraction Tool (ELEFT)EchoSolv AS (Tool A) innovates by providing ultra-fast, measurement-based AI analysis of existing echocardiogram data for severe AS. ELEFT (Tool B) demonstrates a higher degree of innovation by integrating AI directly into a digital stethoscope for real-time, non-invasive early detection of low ejection fraction during routine physical exams, bringing advanced diagnostics to the point of care.
Support & Docs
Eko Low Ejection Fraction Tool (ELEFT)ELEFT (Tool B) explicitly mentions a 'Help Center' with user manuals and FAQs, as well as options to 'Talk to Sales' and 'Live Demo + Q&A' on its website. The provided information for EchoSolv AS (Tool A) does not detail its support or documentation offerings, making Tool B appear more transparent in its support resources.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | EchoSolv AS | Eko Low Ejection Fraction Tool (ELEFT) |
|---|---|---|
| Name | EchoSolv AS | Eko Low Ejection Fraction Tool (ELEFT) |
| Company | Echo IQ | Eko Health |
| Primary Condition Detected | Severe aortic stenosis (sAS) | Low ejection fraction (key indicator of heart failure) |
| Analysis Method | Measurement-based AI (analyzes numerical measurements, not images) | Analyzes ECG and heart sound recordings |
| Speed of Analysis | Under 3 seconds | Approximately 15 seconds |
| Key Integrations | Designed to fit existing workflows (no EMR integration required, integrates with PACS) | Integrates with FDA-cleared Eko digital stethoscopes |
Videos
Demos, reviews, and walkthroughs featuring EchoSolv AS and Eko Low Ejection Fraction Tool (ELEFT).
Frequently Asked Questions
More Comparisons
More matchups featuring EchoSolv AS or Eko Low Ejection Fraction Tool (ELEFT)
Backers
Who funded each tool's parent company.